Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France

BACKGROUND AND AIMS: Tenofovir disoproxil fumarate (TDF) demonstrated potent and sustainable antiviral efficacy and a good safety profile in patients with chronic hepatitis B (CHB) in controlled clinical trials. Real-world data are important to confirm effectiveness and safety data in patient popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcellin, Patrick, Zoulim, Fabien, Hézode, Christophe, Causse, Xavier, Roche, Bruno, Truchi, Régine, Pauwels, Arnaud, Ouzan, Denis, Dumortier, Jérôme, Pageaux, Georges-Philippe, Bourlière, Marc, Riachi, Ghassan, Zarski, Jean-Pierre, Cadranel, Jean-François, Tilliet, Valérie, Stern, Christiane, Pétour, Pascal, Libert, Olivier, Consoli, Silla M., Larrey, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020114/
https://www.ncbi.nlm.nih.gov/pubmed/26821154
http://dx.doi.org/10.1007/s10620-015-4027-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020114/
https://www.ncbi.nlm.nih.gov/pubmed/26821154
http://dx.doi.org/10.1007/s10620-015-4027-8

Ejemplares similares